Keyphrases
Rett Syndrome
100%
Mouse Model
37%
QT Prolongation
36%
Adult Female
33%
Heterozygous Mice
33%
Early Myoclonic Encephalopathy
33%
Interictal Discharges
33%
Systemic Complications
33%
Methyl-CpG-binding Protein 2 (MeCP2)
33%
Rome
33%
COVID-19
33%
Acute Ischemic Stroke
33%
Dextromethorphan
33%
BRAT1
33%
Single Center
33%
Perampanel
33%
HIVEP2
33%
SYNGAP1
33%
Delta Power
33%
Neurobehavioral Phenotype
33%
Open-label Trial
33%
Genotype
33%
AIMP1
33%
Epilepsy
33%
Inflammation
33%
Dendrimer
33%
Ketogenic Diet
33%
Off-label Use
33%
Interictal Epileptiform Discharges
33%
KCNB1
33%
Glial Dysfunction
33%
Nanotherapeutics
33%
Multisystemic
33%
Critically Ill Pediatric Patients
33%
Lateralized Periodic Discharges
33%
Lateralized Rhythmic delta Activity
33%
Seizure
23%
Clinical Severity
19%
Sleep Patterns
16%
Epileptiform Activity
16%
Clinical Seizure
13%
Minerals Level
11%
Protein-losing Enteropathy
11%
Serious Complications
11%
Renal Function Tests
11%
Hypoglycemia
11%
Carnitine Level
11%
Glial Inflammation
11%
Urinalysis
11%
Following System
11%
Neuroscience
Rett Syndrome
100%
Encephalopathy
66%
Ictal
66%
Microcephaly
41%
Magnetic Resonance Imaging of Brain
36%
Dextromethorphan
33%
Perampanel
33%
Open-Label Trial
33%
Apraxia
33%
Ataxia
33%
SCN1B
33%
Electroencephalogram
23%
Status Epilepticus
22%
Ketogenic Diet
19%
Antiseizure Medication
19%
Exome Sequencing
16%
Intractable Epilepsy
16%
Dysautonomia
16%
Fenfluramine
13%
Metabolic Pathway
13%
Rapid Eye Movement Sleep
13%
Magnetic Resonance Imaging
11%
Myelinogenesis
8%
Corpus Callosum
8%
Neurodegenerative Disorder
8%
Hypoplasia
8%
MECP2
8%
Cerebellar Vermis
8%
Cannabidiol
8%
Glia
6%
Synaptogenesis
6%
Sleep Pattern
6%
Cytokine Production
6%
Hippocampus
6%
Electroencephalography
6%
Acetylcysteine
6%
Proinflammatory Cytokine
6%
Neurodevelopmental Disorder
6%
Striatum
6%
Glial Cells
6%
Anti-Seizure Medication
5%
Myoclonic Seizure
5%
Medicine and Dentistry
Brain Disease
66%
Ketogenic Diet
52%
Burst Suppression
33%
Brain Ischemia
33%
Side Effect
33%
SCN1B
33%
COVID-19
33%
Genetic Variability
33%
Apoplexy
33%
Cannabidiol
25%
Status Epilepticus
22%
Intractable Epilepsy
16%
Fenfluramine
13%
Adverse Event
11%
Epileptic Seizure
11%
Nasopharyngeal Swab
10%
Symptom
9%
Protein Losing Enteropathy
8%
Hypoglycemia
8%
Electroencephalogram
8%
Shallow Breathing
8%
Kidney Function Test
8%
Neurologic Disease
8%
QT Prolongation
8%
Pancreatitis
8%
Degenerative Disease
8%
Carnitine
8%
Newborn Period
8%
Corpus Callosum Agenesis
8%
Developmental Delay
8%
Drug Therapy
8%
Clinical Feature
8%
Metabolic Acidosis
8%
Microcephaly
8%
Gastrointestinal System
8%
Liver Enzyme
8%
Failure to Thrive
8%
Cardiomyopathy
8%
Magnetic Resonance Imaging of Brain
8%
Myelination
8%
Treatment of Epilepsy
8%
Motor Development
8%
Cardiovascular System
8%
Urinalysis
8%
Muscle Hypertonia
8%
Basal Ganglia
8%
Severe Acute Respiratory Syndrome Coronavirus 2
6%
Large Vessel Occlusion
6%
Disease
6%
Myoclonus Seizure
5%
